By Erich Martin
Approximately 20% of patients with solid organ transplants, rare autoimmune rheumatic diseases or lymphoid cancers fail to mount a response to three or more COVID-19 vaccine doses, according to data published in The Lancet Rheumatology.
However, the researchers additionally concluded that the proportion of patients who are non-responders decreases with sequential booster doses. Read the full article in Healio.